Novo Holdings to buy Catalent for $16.5B



Novo Holdings A/S, the holding company for pharmaceutical Novo Nordisk, announced on Monday that it is acquiring Catalent Inc. for $16.5 billion in cash at $63.50 per share, representing a 16.5% premi…
About the author:

Get involved!

Fai trading in gruppo!
L'unica Academy di trading completamente gratuita per gli utenti FpMarkets

Comments

Ancora nessun commento